ERDERA Clinical Trial Call – Annex IV. Guidelines for Canadian Applicants

This annex explains the specific eligibility, sponsorship, funding and application requirements for Canadian applicants in the ERDERA Clinical Trial Call.

This annex sets out the eligibility criteria, sponsor requirements, funds management rules, and application steps that apply to Canadian applicants requesting funding from the Canadian Institutes of Health Research (CIHR) within the ERDERA Clinical Trial Call (ECTC). It explains who is eligible, the requirement for an EU or Norwegian legal sponsor, how CIHR and ERDERA central funding are managed for Canadian partners, and the Stage 3 submission requirements for Canadian applicants.

Acces this publication

publication

ERDERA clinical trial call

Year of publication

2026

Author

European Rare Diseases Research Alliance (ERDERA)

You might also be interested in

ERDERA - GAM day 2 - JVDPhotography-65

ERDERA announces its 2026 Open Session

This free online session will highlight patient and research perspectives, innovative clinical study methods, and emerging regulatory approaches
ERDERA trainings template (7)

Regulatory Insights of Advanced Therapies Research & Development

September 30 @ 1:00 pm - 2:00 pm
This ERDERA webinar will provide an overview of the regulatory and ethical requirements for advanced therapy medicinal product (ATMP) research, with a particular focus on genome editing and paediatric studies in rare diseases.
October 2026 (5)

ERDERA’s Open Session – 3rd General Assembly Meeting

October 21 @ 2:30 pm - 5:30 pm
A special anniversary event showcasing how innovation, collaboration and novel trial methodologies are advancing rare disease research.
ERDERA trainings template (9)

The 2027 Open Academy x ERDERA Schools is now open for application

Applications for the 2027 Open Academy x ERDERA Schools offer patient advocates and early-career researchers the opportunity to strengthen their knowledge and participation in rare disease research.

ERDERA Search